Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Servier CDMO
Sort By
Newest First
1 / 2
1 / 2
The Road to 2021
Road to 2021 Day 24: France
Nigel Walker
Nice Insight
PAO-04-22-R221-51
Jan 01, 2021
Servier Acquires Symphogen
Servier
PR-M04-20-NI-006
Apr 03, 2020
Serialization Update
Revisiting the Global Serialization Landscape
Michael Kinsella
Servier
PAP-Q2-2019-CL-030
May 24, 2019
Expansion
Servier Cuts Ribbon on New Boston Headquarters
Servier
PR-M05-19-NI-037
May 13, 2019
DCAT '19
Highly Potent API and Sterile Capabilities Key to DCAT Week ‘19 Company Announcements
David Alvaro, Ph.D.
Pharma's Almanac
PAO-M03-19-NI-024
Mar 18, 2019
Collaboration
Amgen, Cytokinetics and Servier Announce Start Of METEORIC-HF, The Second Phase 3 Clinical Trial Of Omecamtiv Mecarbil In Patients With Heart Failure
Amgen
PR-M02-19-NI-052
Feb 22, 2019
Global Network
Risk Minimization with an Integrated Global Network
Servier
PAP-Q4-18-CL-005
Oct 26, 2018
Design Logic
Preparative Chromatography
Nice Insight
PAP-Q4-18-NI-002
Oct 26, 2018
Chromatography
Accelerating Time to Market with Integrated Preparative Chromatography Support
Christophe Berini
Servier
PAP-Q3-18-CL-010
Oct 02, 2018
Announcement
Shire Exec Selected to Run Servier Pharmaceuticals U.S.
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-M07-18-NI-015
Jul 24, 2018
Regulatory
Reducing Time to Market with Targeted Regulatory Affairs Support
Maryse Phan
Servier
PAO-06-18-CL-003
Jun 20, 2018
Corporate Social Responsibility
Corporate Social Responsibility as a Driver for Improved Sustainability
Allain de Wilde; Loïc Allanos
Servier
PAP-Q2-18-CL-014
May 29, 2018
Endpoint
Phase III Study Evaluating the Efficacy and Safety of Lonsurf in Patients with Metastatic Gastric Cancer Meets Primary Endpoint
Servier
PR-M05-18-NI-040
May 10, 2018
Acquisition
Shire Announces Sale of Oncology Business to Servier for $2.4 Billion
Servier
PR-M04-18-NI-59
Apr 16, 2018
Operational Excellence
Transforming A CDMO Using an Operational Excellence Approach
Sébastien Mathieu; Laurent Dray
Servier
PAO-M03-18-CL-003
Mar 29, 2018
Innovation
WeHealth by Servier and DEEPLINK MEDICAL sign a partnership to develop a new e-health solution
Servier
PR-M03-18-NI-059
Mar 16, 2018
Industry
Why Business Continuity Management is Important for CDMOs
Mayeul Cauvin
Servier
PAP-Q1-18-CL-003
Mar 12, 2018
Servier Reports Year-On-Year Growth
Guy Tiene
Nice Insight
PAO-M02-18-NI-024
Feb 27, 2018
Strategic Partnership
ImmunoQure AG and Servier Enter into Strategic Partnership for the Development of an Interferon-alpha Human Autoantibody
Servier
PR-M02-18-NI-64-4706
Feb 14, 2018
Symposium
Taiho Oncology and Servier Present LONSURF® (trifluridine and tipiracil) Metastatic Colorectal Cancer (mCRC) Data at ASCO 2018 Gastrointestinal Cancers Symposium
Taiho Oncology, Inc.
PR-M01-18-NI-080
Jan 25, 2018
